Fortrea Appoints William Sharbaugh to Board, Expands Board to Eight Directors
Fortrea Holdings Inc. increased its authorized board size to eight and appointed William J. Sharbaugh as a Class III director, effective September 22, 2025. Sharbaugh has more than three decades of pharmaceutical industry experience and was not yet named to any board committees.
Key points
- Board approved expanding authorized directors to eight on September 19, 2025.
- William J. Sharbaugh appointed Class III director effective September 22, 2025, serving until the 2026 Annual Meeting of Stockholders.
- Sharbaugh will receive director compensation under the Company's non-employee director compensation policy; no committee assignments have been decided.
- Sharbaugh previously served as chief operating officer at PPD, Inc. from 2007 to 2021.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:56 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 22, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.